More Articles

Access and Evidence

Value-Based Contracting: Do We Have The Data?

Andrew Stone, (Nov 20, 2018)

Deals have been signed. Promises have been made. But are companies delivering the goods?
Patients and Medical

An Unlikely Road To Recovery

Lucy Fulford, (Nov 15, 2018)

After being diagnosed with a rare disease, Karen Cheng's life drastically altered course, then the unexpected happened.
Patients and Medical

An Impatient Truth

Paul Simms, (Nov 9, 2018)

How patients taught me that pharma’s partnership efforts simply aren’t enough
Access and Evidence

How To Illustrate Your RWE To Payers

Adam Chapman, (Nov 1, 2018)

Data visualization tools are demystifying real-world evidence.
Patients and Medical

How To Trust In The Age Of (Dis)Information

Lucy Fulford, (Oct 30, 2018)

Amid the smoke and mirrors, pharma has an opportunity to set the record straight.
Patients and Medical

I Made An App To Plug A Knowledge Gap

Lucy Fulford, (Oct 24, 2018)

Hellen Marguerite Juul struggled to find information on how to navigate a pregnancy with diabetes, so she came up with her own solution.
Access and Evidence

American Healthcare System 1 - 0 Europe

Andrew Stone, (Oct 23, 2018)

When it comes to pricing and access, the European healthcare system is losing.
Access and Evidence

Working with HTAs: It’s Your Move

Ross Davies, (Oct 16, 2018)

European HTA bodies have signaled that they want greater and earlier dialogue with pharma but is their call being answered?
Access and Evidence

Value: A Balancing Act

Ross Davies, (Oct 16, 2018)

When it comes to proving the value of a new medicine, pharma has to strike the right balance
Access and Evidence

Can Payers Trust Our Data?

Andrew Stone, (Oct 16, 2018)

Analyses from RWD are playing an increasingly important role, but will payers accept pharma’s figures?

Pages